Improving Maximal Strength in the Initial Postoperative Phase After Anterior Cruciate Ligament Reconstruction Surgery: Randomized Controlled Trial of an App-Based Serious Gaming Approac

Sponsor
Hannover Medical School (Other)
Overall Status
Completed
CT.gov ID
NCT04224376
Collaborator
(none)
26
2
30

Study Details

Study Description

Brief Summary

The investigators designed a prospective randomized trial to evaluate whether an app based active muscle training program (GenuSport) can improve the postoperative strength by starting rehabilitation immediately after primary anterior cruciate ligament (ACL) reconstruction surgery as already shown for patients who underwent total knee arthroplasty. To the investigators knowledge this is the first study analyzing immediate postoperative serious gaming based training with the GenuSport device based on strength improvement.

Condition or Disease Intervention/Treatment Phase
  • Device: App based Serious Gaming with the Genu Sport knee trainer
N/A

Detailed Description

The study is designed as a prospective randomized control trial. Participants awaiting primary ACL reconstruction surgery were recruited at a single tertiary healthcare center between April 2016 and February 2018. An ethical approval has been given by MHH ethic committee and an IRB was involved. Due to different postoperative treatment protocols and different surgical approaches we could include participants between 13 and 46 years. A computer based randomization was performed by generating a list of randomized numbers which have been provided in sealed envelopes by an independent examiner. The postoperative treatment protocol was apart from the use of the GenuSport knee trainer identically standardized. The pain management was the same for all patients, none of the participants received a continuous peripheral nerve block. The postoperative physiotherapy protocol included gait training, assisted walking with crutches, active and passive knee mobilization, strength exercises and stair climbing. In the training group each participant was additionally provided with a GenuSport knee trainer device (prototype plus tablet with software application) with the active knee extension training program for 6 weeks. Except of that fact the postoperative protocol was identical in both groups. Participant had to train five times daily with the knee trainer starting at the day of surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Improving Maximal Strength in the Initial Postoperative Phase After Anterior Cruciate Ligament Reconstruction Surgery: Randomized Controlled Trial of an App-Based Serious Gaming Approac
Actual Study Start Date :
Apr 1, 2016
Actual Primary Completion Date :
Feb 1, 2018
Actual Study Completion Date :
Oct 1, 2018

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Conventional rehabilitation

Normal postoperative treatment protocol with physiotherapy after ACL surgery

Experimental: Serious Gaming

In the training group each patient was additionally provided with a GenuSport knee trainer device (prototype plus tablet with software application) with the active knee extension training program for 6 weeks. Other postoperative treatment was identical.

Device: App based Serious Gaming with the Genu Sport knee trainer
The Genu Sport knee trainer has a strength monitoring unit with three integrated sensors which is placed in the popliteal area and a tablet with the application which allows to transfer the raised force into the game modus. Each training session in our study takes around 5 minutes and is performed autonomously by the patient in his bed with 45° degrees of upper body evaluation while the patient holds the tablet in both hands. By simply pushing his knee downward onto the measuring unit the patient can apply the force.

Outcome Measures

Primary Outcome Measures

  1. Absolute and relative change in maximum strength [6 weeks]

    Primarily, change in maximum strength was analyzed both, as an absolute difference between week 6 and pre-surgery value (6 weeks - pre-surgery) and as a relative change (6 weeks / pre-surgery).

Secondary Outcome Measures

  1. Change in clinical outcome [6 weeks]

    IKDC, Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms)

  2. Change in clinical outcome [6 weeks]

    KOOS

  3. Change in clinical outcome [6 weeks]

    Tegner activity scale, scale of 0 to 10. Zero represents disability because of knee problems and 10 represents national or international level soccer

  4. Change in clinical outcome [6 weeks]

    Lysholm, Maximum 100 points higher score means better Outcome

  5. Change in clinical outcome [6 weeks]

    VAS score, Values 0 to 10 higher values mean a worse outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients awaiting primary ACL reconstruction surgery

  • Willingness to participate

  • Ability to work with an app based training device

Exclusion Criteria:
  • Additional meniscal suturing

  • Additional collateral ligament repair

  • Additional regenerative cartilage treatment

  • Unwillingness to participate in the study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hannover Medical School

Investigators

  • Principal Investigator: Thomas Sanjay Weber-Spickschen, MD, Trauma Departement, Hanover Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Clausen, Jan-Dierk Dr., Principal Investigator, Hannover Medical School
ClinicalTrials.gov Identifier:
NCT04224376
Other Study ID Numbers:
  • 3102-2016 VKB
First Posted:
Jan 13, 2020
Last Update Posted:
Jan 18, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Clausen, Jan-Dierk Dr., Principal Investigator, Hannover Medical School
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2020